Browsing Tag

PRNewswire

54236 posts
Mega Matrix Corp. Announced that FlexTV Formed the Strategic Cooperation with TopReels, the leading short drama platform in South Korea

Mega Matrix Corp. Announced that FlexTV Formed the Strategic Cooperation with TopReels, the leading short drama platform in South Korea

PALO ALTO, Calif., May 24, 2024 /PRNewswire/ — Mega Matrix Corp. ("MPU"…
Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024

Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024

SHANGHAI, May 24, 2024 /PRNewswire/ — Shanghai Juncell Therapeutics Co., Ltd. (Juncell…
Tyfon and Global Technology Acquisition Corp. I Announce Public Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination

Tyfon and Global Technology Acquisition Corp. I Announce Public Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination

•         Transaction expected to close in the second half of 2024 ZEPHYR…
Unlocking the Next Level: Esteemed fashion leaders assemble in Copenhagen to catalyse and accelerate sustainability progress

Unlocking the Next Level: Esteemed fashion leaders assemble in Copenhagen to catalyse and accelerate sustainability progress

COPENHAGEN, Denmark, May 24, 2024 /PRNewswire/ — On 21-23 May, Global Fashion Summit:…
YS Biopharma Announces Name Change to LakeShore Biopharma

YS Biopharma Announces Name Change to LakeShore Biopharma

GAITHERSBURG, Md., May 24, 2024 /PRNewswire/ — YS Biopharma Co., Ltd. (Nasdaq:…
XCMG Machinery Amplifies Presence in Latin America with More Tailor-Made Machines Launched

XCMG Machinery Amplifies Presence in Latin America with More Tailor-Made Machines Launched

SAO PAULO, May 24, 2024 /PRNewswire/ — In a significant move to…
Rokid AR Lite: The first AR glasses powered by Snapdragon® 6 Gen 1 mobile platform

Rokid AR Lite: The first AR glasses powered by Snapdragon® 6 Gen 1 mobile platform

REDWOOD CITY, Calif., May 24, 2024 /PRNewswire/ — Rokid has announced the launch of…
61st ERA Congress: Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals

61st ERA Congress: Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals

STOCKHOLM, May 24, 2024 /PRNewswire/ — A pioneering study, presented today at…